FipX

FipX delivers pure EIDD-1931, the active antiviral metabolite of molnupiravir, in a formulation designed exclusively for feline physiology. EIDD-1931 does not require metabolization in the liver, thus significantly reducing liver stress typically associated with prolonged Molnupiravir (EIDD-2801) treatments. By using EIDD-1931 directly, rather than modifying human molnupiravir capsules, FipX provides a more potent, precise, and consistent veterinary-appropriate approach to FIP care, while significantly reducing any potential side effects associated with prolonged Molnupiravir treatments.

Purpose-Built Feline Formulation

Each FipX capsule contains 15 mg of EIDD-1931, equivalent in activity to approximately 66 mg of molnupiravir (EIDD-2801).

This formulation is optimized for:

• Feline metabolic rate

• Gastrointestinal absorption profile

• Reliable dose–response performance

The result is accurate, predictable antiviral activity with reduced variability compared to human-intended products.

Antiviral Potency in Research

Published research demonstrates that:

• EIDD-1931 exhibits up to 10× greater in-vitro antiviral potency compared with molnupiravir (EIDD-2801).

• EIDD-1931 demonstrates 7.3× higher potency than GS-441524 under similar test conditions.

This potency advantage enables therapeutic efficacy at lower milligram doses, supporting improved tolerability and rapid clinical response.

Reference:

Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity Against Enterovirus Infections In Vitro and In Vivo

https://www.mdpi.com/1999-4915/14/6/1142

Comprehensive Support Across FIP Presentations

MolnuFIP is formulated to support recovery across all major forms of FIP, including:

• Wet FIP (effusive)

• Dry FIP (non-effusive)

• Mixed or transitional presentations

Additional formulation benefits:

• Optimized for feline metabolism and tissue penetration

• Highly consistent blood-level performance

• Designed to support low relapse incidence when used according to veterinary guidance

Precision, Safety & Confidence in Every Dose

With FipX, your cat receives an advanced, veterinary-formulated antiviral designed for targeted and reliable performance:

• Scientifically grounded formulation

• Consistent mg-per-kg dosing

• No need to modify human medications

• Backed by modern antiviral research

FipX provides a clearer, more controlled path to FIP recovery, supporting your cat’s return to comfort, vitality, and quality of life.

Active Ingredient

EIDD-1931

Inactive Ingredient

Dibasic Calcium Phosphate, Magnesium Sterate

Form

Size #3 Capsules

Indications

Ideal for felines with effusive (wet) and non-effusive (dry) feline infectious peritonitis (FIP)

Specification

60 capsules, each containing 15 mg of EIDD-1931

Dosage

1 capsule every 12 hours for every 2.5 kg of body weight, preferably on an empty stomach.

If vomiting occurs within 30 minutes, administer another capsule.

Not Recommended Use

1. Ocular or neurological FIP cases.

2. Cats not feeding or defecating normally

3. Cats with a history of poor dietary absorption.

Length of Treatment

Up to 60 days or as recommended by a veterinarian.

Storage

Store in a dry, cool place away from sunlight.

Packaging

Each pack contains 60 capsules in vacuum-sealed mylar bag.

For cats weighing up to 2.5kg package use 60 capsules every 30 days.

For cats weighing 2.5 to 5kg package use 120 capsules every 30 days.

For cats weighing above 5kg package contains 180 capsules every 30 days.

Expiration: 12 months

All orders are processed and dispatched within 24 hours using secure, tamper-evident, and discreet packaging to safeguard product integrity during transit.

We offer fast local shipping to most destinations across Europe, GCC,, Asia, North America, and South America, with typical delivery times of 2–5 business days.

For destinations that require international shipping, shipments are handled by DHL and FedEx for maximum reliability and tracking accuracy.

Domestic deliveries are fulfilled through trusted local express couriers to ensure prompt arrival.

Dosage Instructions

Below 2.5kg, 1 capsules every 12 hours

2.5 kg ~ 5 kg, 2 capsules every 12 hours

Above 5 kg, 3 capsules every 12 hours

Dosing Examples

• Example 1: A 2.0 kg kitten diagnosed with the effusive (wet) form of FIP should receive one capsule every 12 hours.

• Example 2: A 4.6 kg adult cat diagnosed with the non-effusive (dry) form of FIP should receive two capsules every 12 hours.

Monitoring and Follow-Up

We strongly recommend that your cat receives a complete blood panel approximately every 30 days, in conjunction with ongoing evaluation by your primary veterinarian. Regular monitoring allows your veterinarian to assess clinical response and determine whether continued treatment, dose adjustment, or discontinuation is appropriate.